Skip to main content

Welcome to the Parexel Resource Center

Find the latest resources on regulatory, clinical development, biotech, and more. Browse our content below.

Payer insights for cell and gene therapies

It is essential to address the payer landscape very early in development for a product administered once with a lifelong effect, such as a gene therapy. The one-time, front-loaded costs of these treatments have necessitated new payment models to win payer approval and be affordable. In this short video, Emma Medin, VP, Pricing & Market Access, shares three payer insights to help you price appropriately for your cell or gene therapy. Get more insights from our experts by visiting